The Trans-Pacific Health Sciences Dialogue is a C-level meeting for biopharmaceutical industry executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
Over the course of two days, executives, dealmakers, investors, professional advisors and KOLs with deep trans-pacific experience will share their insights and experiences in an intimate and collegial setting that encourages interaction and collaboration. The program features informative panel discussions and case studies that focus on best practices to create growth, achieve objectives, add value and minimize risk on both sides of the Pacific.
The Health Sciences Dialogue is a must-attend meeting for executives whose strategy includes establishing a Trans-Pacific collaboration or investment. Attendees will come away with a broad overview and insights that they simply will not get in other meetings.
Background
Now in its fourteenth year, the Health Sciences Dialogue was established to improve the productivity of partnerships between Asian and North American biopharmaceutical companies and their stakeholders. The event has developed a reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options.
Organizers
The Trans-Pacific Health Sciences Dialogue is organized by Demy-Colton Life Science Advisors with the support of the Japan America Society of Greater Philadelphia.